Semaglutide and Type 2 Diabetes Contact Hours: 2 Author(s): Maureen Sullivan-Tevault RN, BSN, CEN, CDCES Course Highlights In this course, you will learn about the mechanisms and clinical applications of GLP-1 injectable medications, specifically semaglutide, in managing Type 2 diabetes and its associated health risks
The clinician can also help determine whether standard care, physical therapy, imaging, nutrition, sleep optimization, hormone evaluation, or another treatment should come first
The higher proportion of women in this group could be due to the effects of the menstrual cycle
See TABLES 2 and 3 for additional counseling points for patients prescribed GLP-1 therapy
Die empfohlene Tagesdosis sollte nicht berschritten werden
Tridimensional structural organization of Dipeptidyl Peptidase-4 (DPP-4) with its locations for extracellular, transmembrane, and intracytoplasmic regions, as well as the main functional domains